Brendan O'Malley - 28 Sep 2022 Form 4 Insider Report for ABEONA THERAPEUTICS INC. (ABEO)

Role
SVP, General Counsel
Signature
/s/ Brendan O'Malley
Issuer symbol
ABEO
Transactions as of
28 Sep 2022
Net transactions value
$0
Form type
4
Filing time
30 Sep 2022, 16:05:38 UTC
Previous filing
22 Sep 2022
Next filing
21 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABEO Common stock Award $0 +72,750 +943% $0.000000 80,461 28 Sep 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock will vest 25% on each of September 28, 2023, September 28, 2024, September 28, 2025 and September 28, 2026.
F2 On September 22, 2022, the reporting person filed a Form 4 that inadvertently reported an additional 1,360 shares of common stock as beneficially owned in Column 5. The amount disclosed in Column 5 above rectifies that error.